Janne Johannes Soikkeli
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Janne Johannes Soikkeli has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Aleksi Reito
Coxa Hospital for Joint Replacement and Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland
2 shared publications - Mikko Petteri Räisänen
Faculty of Medicine and Health Technology, Tampere University, Arvo Ylpön katu 34, 33520, Tampere, Finland
2 shared publications - Olli Ville Leppänen
Department of Hand and Microsurgery, Tampere University Hospital, Tampere, Finland
2 shared publications - Teemu Karjalainen
Department of Hand and Microsurgery, Tampere University Hospital, Tampere, Finland
2 shared publications Annele Pönkkö
Department of Hand Surgery and Orthopedics, Oulu University Hospital, Oulu, Finland (J.S., A.P.)
1 shared publication- Antti Kaivorinne
Department of Hand and Microsurgery, Tampere University Hospital, Tampere, Finland (O.V.L., A.K.)
1 shared publication
Latest Publications
- Open Access
- 19 March 2025
- Published by Medical Journals Sweden AB in Journal of Plastic Surgery and Hand Surgery
- Vol. 60, 71-77
Nationwide rates of limited fasciectomy for Dupuytren’s contracture: data from the Finnish National Registry
Dupuytren’s contracture (DC) is often treated with limited fasciectomy (LF), while percutaneous treatment options are gaining popularity. The recent trends in the incidence rates of LF are not well known. Our study aimed to investigate the incidence rates of LF over time, and we collected nationwide data on all LF performed between January 1, 1997 and December 31, 2018. The main outcome variables were the incidence rates of first and subsequent LF for each patient per 100,000 person-years, calculated for each study year, gender, and age group. Data were obtained from the Finnish National Hospital Discharge Registry, which covers the entire population of Finland. Reporting to the registry is mandatory for all public and private hospitals, and the validity has been found to be excellent. All adult patients with a diagnosis code of M72.0 for DC and a surgical procedure code of NDM10 for LF were included in this study. The incidence rate of the first LF declined from 36.5 to 11.7, while the rate of subsequent LF increased from 2.3 to 14.0 from 1997 to 2011 and then declined to 9.3 in 2018. LF was performed significantly more often in men than in women (ratio 4:1). Additionally, it was performed significantly more often in patients between 60 and 79 years than in other age groups. Despite the estimated increase in the prevalence of DC, our data show that the incidence rate of first LF has declined, and there was no discernible consistent trend in the incidence of subsequent LF during the same period.
- 19 March 2025
- Published by Medical Journals Sweden AB in Journal of Plastic Surgery and Hand Surgery
- Vol. 60, 71-77
Open AccessNationwide rates of limited fasciectomy for Dupuytren’s contracture: data from the Finnish National Registry
Dupuytren’s contracture (DC) is often treated with limited fasciectomy (LF), while percutaneous treatment options are gaining popularity. The recent trends in the incidence rates of LF are not well known. Our study aimed to investigate the incidence rates of LF over time, and we collected nationwide data on all LF performed between January 1, 1997 and December 31, 2018. The main outcome variables were the incidence rates of first and subsequent LF for each patient per 100,000 person-years, calculated for each study year, gender, and age group. Data were obtained from the Finnish National Hospital Discharge Registry, which covers the entire population of Finland. Reporting to the registry is mandatory for all public and private hospitals, and the validity has been found to be excellent. All adult patients with a diagnosis code of M72.0 for DC and a surgical procedure code of NDM10 for LF were included in this study. The incidence rate of the first LF declined from 36.5 to 11.7, while the rate of subsequent LF increased from 2.3 to 14.0 from 1997 to 2011 and then declined to 9.3 in 2018. LF was performed significantly more often in men than in women (ratio 4:1). Additionally, it was performed significantly more often in patients between 60 and 79 years than in other age groups. Despite the estimated increase in the prevalence of DC, our data show that the incidence rate of first LF has declined, and there was no discernible consistent trend in the incidence of subsequent LF during the same period.
- 1 March 2024
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 177 (3) , 280-290
Surgery, Needle Fasciotomy, or Collagenase Injection for Dupuytren Contracture
Surgery, needle fasciotomy, and collagenase injection are used to treat Dupuytren contracture. The treatment decision requires balancing initial morbidity and costs of surgery against its potential long-term benefits over needle fasciotomy and collagenase. To compare the effectiveness of surgery, needle fasciotomy, and collagenase injection at 3 months and 2 years (secondary time points of the trial). A multicenter, randomized, outcome assessor-blinded, superiority trial. (ClinicalTrials.gov: NCT03192020). 6 public hospitals in Finland. 302 persons with treatment-naive Dupuytren contracture (contracture angle n = 101), needle fasciotomy (n = 101), or collagenase (n = 100). The primary outcome was the success rate, defined as greater than 50% contracture release and patients reaching the patient acceptable symptom state. Secondary outcomes included hand function, pain, quality of life, patient satisfaction, residual contracture angle, finger flexion, risk for retreatment, and serious adverse events. A total of 292 (97%) and 284 (94%) participants completed the 3-month and 2-year follow-ups. Success rates were similar at 3 months: 71% (95% CI, 62% to 80%) for surgery, 73% (CI, 64% to 82%) for needle fasciotomy, and 73% (CI, 64% to 82%) for collagenase. At 2 years, surgery had superior success rates compared with both needle fasciotomy (78% vs. 50%; adjusted risk difference [aRD], 0.30 [CI, 0.17 to 0.43]) and collagenase (78% vs. 65%; aRD, 0.13 [CI, 0.01 to 0.26]). Secondary analyses paralleled with the primary analysis. Participants were not blinded. Initial outcomes are similar between the treatments, but at 2 years success rates were maintained in the surgery group but were lower with both needle fasciotomy and collagenase despite retreatments. Research Council of Finland.
- 1 March 2024
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 177 (3) , 280-290
Surgery, Needle Fasciotomy, or Collagenase Injection for Dupuytren Contracture
Surgery, needle fasciotomy, and collagenase injection are used to treat Dupuytren contracture. The treatment decision requires balancing initial morbidity and costs of surgery against its potential long-term benefits over needle fasciotomy and collagenase. To compare the effectiveness of surgery, needle fasciotomy, and collagenase injection at 3 months and 2 years (secondary time points of the trial). A multicenter, randomized, outcome assessor-blinded, superiority trial. (ClinicalTrials.gov: NCT03192020). 6 public hospitals in Finland. 302 persons with treatment-naive Dupuytren contracture (contracture angle n = 101), needle fasciotomy (n = 101), or collagenase (n = 100). The primary outcome was the success rate, defined as greater than 50% contracture release and patients reaching the patient acceptable symptom state. Secondary outcomes included hand function, pain, quality of life, patient satisfaction, residual contracture angle, finger flexion, risk for retreatment, and serious adverse events. A total of 292 (97%) and 284 (94%) participants completed the 3-month and 2-year follow-ups. Success rates were similar at 3 months: 71% (95% CI, 62% to 80%) for surgery, 73% (CI, 64% to 82%) for needle fasciotomy, and 73% (CI, 64% to 82%) for collagenase. At 2 years, surgery had superior success rates compared with both needle fasciotomy (78% vs. 50%; adjusted risk difference [aRD], 0.30 [CI, 0.17 to 0.43]) and collagenase (78% vs. 65%; aRD, 0.13 [CI, 0.01 to 0.26]). Secondary analyses paralleled with the primary analysis. Participants were not blinded. Initial outcomes are similar between the treatments, but at 2 years success rates were maintained in the surgery group but were lower with both needle fasciotomy and collagenase despite retreatments. Research Council of Finland.